{"transactions":[{"id":722831,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:20:56.000Z","date":"2026-06-29","kind":"gift","planned":false,"acquired":false,"shares":51813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code."}],"balance_after":52097,"source":{"system":"sec-edgar","filing":"0001193125-26-290586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526290586/ownership.xml","form_type":"4"}},{"id":760283,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":43534,"kind":"person","name":"Friedman David Matthew","position":1,"cik":"0002108980","reported_name":"Friedman David Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2026-05-29T01:10:14.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as a Managing Director of Suvretta Capital Management, LLC (\"Suvretta Capital\"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the \"Funds\"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital, the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options will vest in full on the earlier of immediately prior to the Issuer's next annual meeting of stockholders and May 26, 2027."}],"balance_after":35000,"derivative":{"exercise_price":11.45,"expiration_date":"2036-05-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-245918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526245918/ownership.xml","form_type":"4"}},{"id":931209,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50018,"kind":"person","name":"Mates Sharon","position":1,"cik":"0001585699","reported_name":"Mates Sharon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2026-01-26T21:10:15.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":31500,"derivative":{"exercise_price":12.83,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001012975-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297526000082/form4.xml","form_type":"4"}},{"id":958444,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":11587,"price":13.44,"value":155729.28,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Notes are included on Exhibit 99.1."}],"balance_after":1848156,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958443,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":65800,"price":13.44,"value":884352.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":9700195,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958442,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":2516,"price":13.1,"value":32959.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1836569,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958441,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":14320,"price":13.1,"value":187592.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":9634395,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958440,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":7400,"price":12.85,"value":95090.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1834053,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958439,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":42600,"price":12.85,"value":547410.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9620075,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":961233,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":2892,"price":12.08,"value":34935.36,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Notes are included on Exhibit 99.1."}],"balance_after":1826653,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961232,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":16650,"price":12.08,"value":201132.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":9577475,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961231,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":2434,"price":11.48,"value":27942.32,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1823761,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961230,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":13950,"price":11.48,"value":160146.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":9560825,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961229,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":1515,"price":11.24,"value":17028.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1821327,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961228,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":8700,"price":11.24,"value":97788.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9546875,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":981675,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50018,"kind":"person","name":"Mates Sharon","position":1,"cik":"0001585699","reported_name":"Mates Sharon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T21:20:40.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":3500,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001012975-25-000851","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000851/form4.xml","form_type":"4"}},{"id":981674,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T21:18:11.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000849","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000849/form4.xml","form_type":"4"}},{"id":981673,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T21:16:17.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000847","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000847/form4.xml","form_type":"4"}},{"id":981715,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T16:19:44.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the \"Funds\") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options.  The Funds, and Suvretta Capital Management, LLC (\"Suvretta Capital\"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000850","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000101297525000850/form4.xml","form_type":"4"}},{"id":981677,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T16:17:12.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000848","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000101297525000848/form4.xml","form_type":"4"}},{"id":992581,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T22:36:30.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":450000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001012975-25-000812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000812/form4.xml","form_type":"4"}},{"id":992580,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T22:35:36.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":200000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001012975-25-000811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000811/form4.xml","form_type":"4"}},{"id":992755,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72839,"kind":"person","name":"Mukadam Sophie","position":1,"cik":"0002050122","reported_name":"Mukadam Sophie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T17:37:42.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":500000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001012975-25-000813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050122/000101297525000813/form4.xml","form_type":"4"}},{"id":1003916,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-11-11T02:51:33.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":751111,"price":13.5,"value":10139998.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1819812,"source":{"system":"sec-edgar","filing":"0000899140-25-001256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001256/form4.xml","form_type":"4"}},{"id":1003915,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-11-11T02:51:33.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":730370,"price":13.5,"value":9859995.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9538175,"source":{"system":"sec-edgar","filing":"0000899140-25-001256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001256/form4.xml","form_type":"4"}},{"id":1004934,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50018,"kind":"person","name":"Mates Sharon","position":1,"cik":"0001585699","reported_name":"Mates Sharon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-11-08T00:50:02.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":28517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026."}],"balance_after":28517,"derivative":{"exercise_price":15.78,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":28517},"source":{"system":"sec-edgar","filing":"0001012975-25-000718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000718/form4.xml","form_type":"4"}},{"id":1184034,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":670,"price":13.22,"value":8857.4,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1068701,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184033,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":5057,"price":13.22,"value":66853.54,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":8807805,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184032,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1267,"price":12.63,"value":16002.21,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1068031,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184031,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":9503,"price":12.63,"value":120022.89,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":8802748,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1188970,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-03-28T20:51:41.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":106200,"price":13,"value":1380600.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1066764,"source":{"system":"sec-edgar","filing":"0000899140-25-000479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000479/form4.xml","form_type":"4"}},{"id":1188969,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-03-28T20:51:41.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":793800,"price":13,"value":10319400.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":8793245,"source":{"system":"sec-edgar","filing":"0000899140-25-000479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000479/form4.xml","form_type":"4"}},{"id":1207864,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:43:09.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":true,"shares":103626,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On March 12, 2025, the reporting person gifted 103,626 shares of Common Stock to a trust for no consideration. The reporting person is trustee of the trust and the reporting person's son is the sole beneficiary."}],"balance_after":103626,"source":{"system":"sec-edgar","filing":"0001062993-25-005393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325005393/form4.xml","form_type":"4"}},{"id":1207863,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:43:09.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":false,"shares":103626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":284,"source":{"system":"sec-edgar","filing":"0001062993-25-005393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325005393/form4.xml","form_type":"4"}},{"id":1236021,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrants (right to buy)","published_at":"2025-03-03T19:20:29.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":51813,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":51813},"source":{"system":"sec-edgar","filing":"0001062993-25-004077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325004077/form4.xml","form_type":"4"}},{"id":1236020,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-03T19:20:29.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":51813,"price":3.86,"value":199998.18,"ownership":{"direct":true},"balance_after":103910,"source":{"system":"sec-edgar","filing":"0001062993-25-004077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325004077/form4.xml","form_type":"4"}},{"id":1321984,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":2288,"price":11.25,"value":25740.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":960554,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321983,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":17730,"price":11.25,"value":199462.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7999455,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321982,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":3142,"price":10.98,"value":34499.16,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":958266,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321981,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":24360,"price":10.98,"value":267472.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7981725,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1335786,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:22:01.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020468/form4.xml","form_type":"4"}},{"id":1335785,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:20:48.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020466","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020466/form4.xml","form_type":"4"}},{"id":1335784,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:19:13.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":2310000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025."}],"balance_after":2310000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":2310000},"source":{"system":"sec-edgar","filing":"0001062993-24-020464","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020464/form4.xml","form_type":"4"}},{"id":1335783,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:17:43.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":720000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025."}],"balance_after":720000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":720000},"source":{"system":"sec-edgar","filing":"0001062993-24-020462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020462/form4.xml","form_type":"4"}},{"id":1335826,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T18:48:27.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the \"Funds\") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options.  The Funds, and Suvretta Capital Management, LLC (\"Suvretta Capital\"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850520/000106299324020503/form4.xml","form_type":"4"}},{"id":1335787,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T17:24:47.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020470","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000106299324020470/form4.xml","form_type":"4"}},{"id":1341847,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-05T21:36:38.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":4810,"price":9.6,"value":46176.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":955124,"source":{"system":"sec-edgar","filing":"0000899140-24-001318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001318/form4.xml","form_type":"4"}},{"id":1341846,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-05T21:36:38.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":37190,"price":9.6,"value":357024.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7957365,"source":{"system":"sec-edgar","filing":"0000899140-24-001318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001318/form4.xml","form_type":"4"}},{"id":1356067,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":3076,"price":10.22,"value":31436.72,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":950314,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356066,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":24360,"price":10.22,"value":248959.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7920175,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356065,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":1570,"price":9.73,"value":15276.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":947238,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356064,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":12430,"price":9.73,"value":120943.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7895815,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1398023,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":148210,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":428137,"derivative":{"exercise_price":0.0001,"exercise_date":"2023-08-11","underlying":"Common Stock","underlying_shares":576347},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398022,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":576347,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":576347},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398021,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":1219970,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":3385030,"derivative":{"exercise_price":0.0001,"exercise_date":"2023-08-11","underlying":"Common Stock","underlying_shares":4605000},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398020,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":4605000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":4605000},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398019,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series 2 Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":10000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":1.9299,"exercise_date":"2022-12-09","expiration_date":"2027-12-09","underlying":"Common Stock","underlying_shares":588236},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398018,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":148210,"price":0.0001,"value":14.821,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":945668,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398017,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":576347,"price":3.86,"value":2224699.42,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":797458,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398016,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":1219970,"price":0.0001,"value":121.997,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7883385,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398015,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":4605000,"price":3.86,"value":17775300.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":6663415,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398014,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":588236,"price":1.9299,"value":1135236.6564,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":2058415,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1586937,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2024-03-08T21:13:15.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":466554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027."}],"balance_after":466554,"derivative":{"exercise_price":5.21,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":466554},"source":{"system":"sec-edgar","filing":"0001062993-24-005970","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324005970/form4.xml","form_type":"4"}},{"id":1586936,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2024-03-08T21:12:19.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":200004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027."}],"balance_after":200004,"derivative":{"exercise_price":5.21,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":200004},"source":{"system":"sec-edgar","filing":"0001062993-24-005969","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324005969/form4.xml","form_type":"4"}},{"id":1719126,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2023-12-08T00:57:35.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":3.1301,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-022120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323022120/form4.xml","form_type":"4"}},{"id":1719125,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2023-12-08T00:55:51.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":3.1301,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-022118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323022118/form4.xml","form_type":"4"}},{"id":1719130,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2023-12-07T19:56:45.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":3.1301,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-022119","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000106299323022119/form4.xml","form_type":"4"}},{"id":1808678,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Common Warrants (right to buy)","published_at":"2023-08-14T21:13:45.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":25907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":25907,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":25907},"source":{"system":"sec-edgar","filing":"0000899243-23-018119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000089924323018119/doc4.xml","form_type":"4"}},{"id":1808677,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Common Stock","published_at":"2023-08-14T21:13:45.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":25907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":25907,"source":{"system":"sec-edgar","filing":"0000899243-23-018119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000089924323018119/doc4.xml","form_type":"4"}},{"id":1808680,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrants (right to buy)","published_at":"2023-08-14T21:10:56.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":51813,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":51813,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":51813},"source":{"system":"sec-edgar","filing":"0000950170-23-042536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000095017023042536/ownership.xml","form_type":"4"}},{"id":1808679,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T21:10:56.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":51813,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023."}],"balance_after":52097,"source":{"system":"sec-edgar","filing":"0000950170-23-042536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000095017023042536/ownership.xml","form_type":"4"}},{"id":1854534,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2023-06-15T20:13:33.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026."}],"balance_after":153000,"derivative":{"exercise_price":0.23,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001062993-23-013639","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323013639/form4.xml","form_type":"4"}},{"id":1854533,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2023-06-15T20:11:50.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":356900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026."}],"balance_after":356900,"derivative":{"exercise_price":0.23,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":356900},"source":{"system":"sec-edgar","filing":"0001062993-23-013634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323013634/form4.xml","form_type":"4"}},{"id":2091229,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2022-12-10T00:22:23.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":0.1682,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299322023660/form4.xml","form_type":"4"}},{"id":2091228,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2022-12-10T00:22:03.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":0.1682,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023659","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299322023659/form4.xml","form_type":"4"}},{"id":2091230,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2022-12-09T19:21:41.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":0.1682,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000106299322023658/form4.xml","form_type":"4"}},{"id":2477382,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2021-12-10T23:56:22.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-21-012696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299321012696/form4.xml","form_type":"4"}},{"id":2477381,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2021-12-10T23:56:05.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-21-012695","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299321012695/form4.xml","form_type":"4"}},{"id":2477383,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2021-12-10T18:55:45.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-21-012694","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000106299321012694/form4.xml","form_type":"4"}},{"id":2479040,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-12-09","kind":"purchase","acquired":true,"shares":10553,"price":3.0443,"value":32126.4979,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2479039,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":37947,"price":3.1804,"value":120686.6388,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":989447,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2479038,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-05-03","kind":"purchase","acquired":true,"shares":40500,"price":4.2537,"value":172274.85,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":951500,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2479037,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-04-30","kind":"purchase","acquired":true,"shares":120000,"price":4.1824,"value":501888.0,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":911000,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2479036,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-04-29","kind":"purchase","acquired":true,"shares":22877,"price":5.491,"value":125617.607,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":791000,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2479035,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":132593,"kind":"person","name":"Oliveira Steven Michael","position":1,"cik":"0001358629","reported_name":"Oliveira Steven Michael","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0,0001 per share","published_at":"2021-12-09T21:55:21.000Z","date":"2021-04-28","kind":"purchase","acquired":true,"shares":100000,"price":5.4486,"value":544860.0,"ownership":{"direct":false,"nature":"Through Nemean Asset Management, LLC"},"balance_after":768123,"source":{"system":"sec-edgar","filing":"0001104659-21-148207","document":"tm2135080-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000110465921148207/tm2135080-2_4.xml","form_type":"4"}},{"id":2948838,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:59:24.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":23601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":23601,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":23601},"source":{"system":"sec-edgar","filing":"0001062993-20-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006261/form4.xml","form_type":"4"}},{"id":2948837,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72280,"kind":"person","name":"Smith Edward F","position":1,"cik":"0001368350","reported_name":"Smith Edward F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:55:31.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":23601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":23601,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":23601},"source":{"system":"sec-edgar","filing":"0001062993-20-006257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006257/form4.xml","form_type":"4"}},{"id":2948836,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:53:29.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":142172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023."}],"balance_after":142172,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":142172},"source":{"system":"sec-edgar","filing":"0001062993-20-006255","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006255/form4.xml","form_type":"4"}},{"id":2948835,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:51:00.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":284345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023."}],"balance_after":284345,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":284345},"source":{"system":"sec-edgar","filing":"0001062993-20-006253","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006253/form4.xml","form_type":"4"}},{"id":2948839,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72281,"kind":"person","name":"Francis Peter","position":1,"cik":"0001808850","reported_name":"Francis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2020-12-11T16:56:58.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":23601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":23601,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":23601},"source":{"system":"sec-edgar","filing":"0001062993-20-006259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808850/000106299320006259/form4.xml","form_type":"4"}}]}